{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05327660",
            "orgStudyIdInfo": {
                "id": "2021-0056"
            },
            "organization": {
                "fullName": "Consumer Wellness Solutions",
                "class": "INDUSTRY"
            },
            "briefTitle": "CO Monitoring for Tobacco Cessation in Quitlines",
            "officialTitle": "Remote Carbon Monoxide Monitoring and Incentives for Tobacco Cessation in Quitlines",
            "therapeuticArea": [
                "Other"
            ],
            "study": "co-monitoring-for-tobacco-cessation-in-quitlines"
        },
        "statusModule": {
            "statusVerifiedDate": "2022-04",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-12-31",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2022-11-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2022-11-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-04-06",
            "studyFirstSubmitQcDate": "2022-04-06",
            "studyFirstPostDateStruct": {
                "date": "2022-04-14",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2022-04-06",
            "lastUpdatePostDateStruct": {
                "date": "2022-04-14",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Consumer Wellness Solutions",
                "class": "INDUSTRY"
            },
            "collaborators": [
                {
                    "name": "Vincere Health",
                    "class": "UNKNOWN"
                },
                {
                    "name": "Maryland State Tobacco Quitline",
                    "class": "UNKNOWN"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The present study is a 3-arm randomized controlled pilot study. Participants who call the Maryland Tobacco Quitline and are eligible for study participation are randomized to receive quitline tobacco cessation treatment as usual (TAU), TAU plus remote carbon monoxide (CO) monitoring via smartphone app, or TAU plus remote carbon monoxide monitoring plus incentives vis smartphone app. We hypothesize that remote CO monitoring will be feasible and acceptable to deliver in the quitline setting, will increase treatment engagement, and will increase tobacco cessation and treatment satisfaction rates."
        },
        "conditionsModule": {
            "conditions": [
                "Tobacco Dependence"
            ],
            "keywords": [
                "tobacco cessation",
                "tobacco quitlines",
                "carbon monoxide monitoring",
                "incentives"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1",
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 300,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Quitline treatment as usual (TAU)",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Quitline services provided by participating state quitlines",
                    "interventionNames": [
                        "Combination Product: Quitline Treatment as Usual (TAU)"
                    ]
                },
                {
                    "label": "Quitline TAU plus remote CO monitoring",
                    "type": "EXPERIMENTAL",
                    "description": "Quitline service plus daily CO monitoring via a smartphone app",
                    "interventionNames": [
                        "Combination Product: Quitline Treatment as Usual (TAU)",
                        "Combination Product: Remote Carbon Monoxide (CO) Monitoring"
                    ]
                },
                {
                    "label": "Quitline TAU plus incentivized remote CO monitoring",
                    "type": "EXPERIMENTAL",
                    "description": "Quitline TAU plus remote CO monitoring with small monetary incentives",
                    "interventionNames": [
                        "Combination Product: Quitline Treatment as Usual (TAU)",
                        "Combination Product: Incentivized Remote CO Monitoring"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "COMBINATION_PRODUCT",
                    "name": "Quitline Treatment as Usual (TAU)",
                    "description": "Quitline TAU is services provided by the state quitline and includes phone coaching, nicotine replacement, supplemental materials (e.g., text messaging, online content).",
                    "armGroupLabels": [
                        "Quitline TAU plus incentivized remote CO monitoring",
                        "Quitline TAU plus remote CO monitoring",
                        "Quitline treatment as usual (TAU)"
                    ]
                },
                {
                    "type": "COMBINATION_PRODUCT",
                    "name": "Remote Carbon Monoxide (CO) Monitoring",
                    "description": "Remote CO monitoring includes a smartphone app and a remote carbon monoxide monitor. The app tracks and prompts daily use of the CO monitor.",
                    "armGroupLabels": [
                        "Quitline TAU plus remote CO monitoring"
                    ]
                },
                {
                    "type": "COMBINATION_PRODUCT",
                    "name": "Incentivized Remote CO Monitoring",
                    "description": "Incentivized remote CO monitoring includes a smartphone app and a remote carbon monoxide monitor. The app tracks and prompts daily use of the CO monitor and delivers small monetary incentives for each use of the CO monitor.",
                    "armGroupLabels": [
                        "Quitline TAU plus incentivized remote CO monitoring"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Treatment satisfaction",
                    "description": "Rating of satisfaction with quitline services on a 6 point scale collected via follow-up survey",
                    "timeFrame": "60 days"
                },
                {
                    "measure": "Treatment engagement",
                    "description": "Number of quitline calls each participant engages in, collected via clinical record system.",
                    "timeFrame": "60 days"
                },
                {
                    "measure": "Self-reported tobacco abstinence",
                    "description": "7 day point prevalence abstinence from all combustible tobacco collected via follow-up survey",
                    "timeFrame": "60 days"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Biochemically verified tobacco abstinence",
                    "description": "CO monitor reading 60 days post randomization (must be 7ppm or less to be considered abstinent) collected via smartphone app",
                    "timeFrame": "60 days"
                },
                {
                    "measure": "Engagement with CO monitor",
                    "description": "Number of times remote CO monitor is used collected via smartphone app.",
                    "timeFrame": "60 days"
                },
                {
                    "measure": "Satisfaction with CO monitor",
                    "description": "Satisfaction with CO monitor measures on 6-point scale collected via follow-up survey",
                    "timeFrame": "60 days"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Daily cigarette smokers calling into participating quitlines\n* 18 year or older\n* Reads and speaks English\n* Has a smartphone with a data plan\n* Willing to download and use study app\n* Willing to use CO monitor\n\nExclusion Criteria:\n\n\u2022 Pregnant or breast feeding",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Caryn Chalmers, MPH",
                    "role": "CONTACT",
                    "phone": "763-330-8300",
                    "email": "caryn.chalmers@optum.com"
                },
                {
                    "name": "Kelly Carpenter, PhD",
                    "role": "CONTACT",
                    "email": "kelly.carpenter@optum.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Kelly Carpenter, PhD",
                    "affiliation": "Consumer Wellness Solutions",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Optum Center for Wellbeing Research",
                    "status": "RECRUITING",
                    "city": "Seattle",
                    "state": "Washington",
                    "zip": "98125",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Caryn Chalmers, MPH",
                            "role": "CONTACT",
                            "phone": "763-330-8300",
                            "email": "caryn.chalmers@optum.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 47.60621,
                        "lon": -122.33207
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30",
            "submissionTracking": {
                "estimatedResultsFirstSubmitDate": "2024-03-20",
                "submissionInfos": [
                    {
                        "releaseDate": "2024-03-20",
                        "resetDate": "2024-04-17",
                        "mcpReleaseN": 1
                    }
                ]
            }
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000014029",
                    "term": "Tobacco Use Disorder"
                }
            ],
            "ancestors": [
                {
                    "id": "D000019966",
                    "term": "Substance-Related Disorders"
                },
                {
                    "id": "D000064419",
                    "term": "Chemically-Induced Disorders"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M16785",
                    "name": "Tobacco Use Disorder",
                    "asFound": "Tobacco Dependence",
                    "relevance": "HIGH"
                },
                {
                    "id": "M21837",
                    "name": "Substance-Related Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M30302",
                    "name": "Chemically-Induced Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC25",
                    "name": "Substance Related Disorders"
                },
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000002248",
                    "term": "Carbon Monoxide"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000963",
                    "term": "Antimetabolites"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000064426",
                    "term": "Gasotransmitters"
                },
                {
                    "id": "D000018377",
                    "term": "Neurotransmitter Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12478",
                    "name": "Nicotine",
                    "relevance": "LOW"
                },
                {
                    "id": "M5506",
                    "name": "Carbon Monoxide",
                    "asFound": "SCD",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4281",
                    "name": "Antimetabolites",
                    "relevance": "LOW"
                },
                {
                    "id": "M20504",
                    "name": "Neurotransmitter Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}